Astromech Acquires Form Bio, Bringing Together Evolutionary AI and Genetic Medicine Design Under One Directive
Astromech has acquired Form Bio in an all-stock transaction valued at $230 million. The deal combines Astromech's evolutionary AI predictive biological models with Form Bio's genetic medicine design tools to help researchers accelerate development across human therapeutics, genome engineering, and animal health. Form Bio co-founder Andrew Busey has joined Astromech as Chief AI Officer and Head of Technology. Open article →